Literature DB >> 12587509

[Impact of regulatory measures in the trends of community consumption of antibiotics in Chile].

Luis Bavestrello1, Angela Cabello, Dunny Casanova.   

Abstract

BACKGROUND: The indiscriminate use of antibiotics increases the appearance of bacterial resistance and forces the use of more expensive alternatives. The Chilean Ministry of Health is regulating the consumption of antibiotics since September 1999. These regulatory measures restricted the sale of antibiotics only when these were prescribed by an MD or an DS. AIM: To study the impact of these regulatory measures on antibiotics sales in pharmacies.
MATERIAL AND METHODS: A retrospective analysis of antibiotics sales in pharmacies from 1996 to 2000. The information was obtained from the International Marketing System (IMS Health), an auditing system of pharmacy sales. The consumption unit used was the Defined Daily Dose per 1000 inhabitants/day (DDD).
RESULTS: There was an important reduction in DDD, after the introduction of regulatory measures, for amoxicillin, ampicillin, erythromycin, trimethoprim/sulpha, chroramphenicol, cloxacillin and phenoxymethylpenicillin. There was also a important fall in sales, expressed in dollars.
CONCLUSIONS: The regulatory measures of the Ministry of Health, had an immediate and great impact on antibiotics sales in Chile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12587509

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  30 in total

Review 1.  Antibiotic use and emerging resistance: how can resource-limited countries turn the tide?

Authors:  Lisa M Bebell; Anthony N Muiru
Journal:  Glob Heart       Date:  2014-10-31

2.  Drug Resistant Infections in Poor Countries: A shrinking window of opportunity.

Authors:  Ralph Gonzales; Kitty K Corbett; Veronika Wirtz; Anahi Dreser
Journal:  BMJ       Date:  2008-04-08

Review 3.  Non-prescription antimicrobial use worldwide: a systematic review.

Authors:  Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg
Journal:  Lancet Infect Dis       Date:  2011-06-12       Impact factor: 25.071

4.  Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions.

Authors:  Yared Santa-Ana-Tellez; Aukje K Mantel-Teeuwisse; Hubert G M Leufkens; Veronika J Wirtz
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

5.  Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs.

Authors:  John M Stelling; Karin Travers; Ronald N Jones; Philip J Turner; Thomas F O'Brien; Stuart B Levy
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

Review 6.  Antimicrobial resistance determinants and future control.

Authors:  Stephan Harbarth; Matthew H Samore
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

7.  Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action.

Authors:  Jean Carlet; Vincent Jarlier; Stephan Harbarth; Andreas Voss; Herman Goossens; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2012-02-14       Impact factor: 4.887

8.  Self-medication practices with antibiotics among tertiary level students in Accra, Ghana: a cross-sectional study.

Authors:  Eric S Donkor; Patience B Tetteh-Quarcoo; Patrick Nartey; Isaac O Agyeman
Journal:  Int J Environ Res Public Health       Date:  2012-10-05       Impact factor: 3.390

9.  Improved STD syndrome management by a network of clinicians and pharmacy workers in Peru: The PREVEN Network.

Authors:  Patricia J García; Cesar P Carcamo; Geoff P Garnett; Pablo E Campos; King K Holmes
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico.

Authors:  Yared Santa-Ana-Tellez; Aukje K Mantel-Teeuwisse; Anahi Dreser; Hubert G M Leufkens; Veronika J Wirtz
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.